Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urea cycle defects: management and outcome.

M C Nassogne1, B Héron, G Touati

  • 1Paediatric Neurology Unit, Department of Paediatrics, Saint-Luc Hospital Brussels, Belgium. marie-cecile.nassogne@nepe.ucl.ac.be

Journal of Inherited Metabolic Disease
|May 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the antiseptic activity of 5% alcoholic povidone-iodine solution using four different modes of application: a randomized open-label study.

The Journal of hospital infection·2022
Same author

[Mucopolysaccharidosis: A review].

La Revue de medecine interne·2020
Same author

Adverse Effects of Treatment with Valproic Acid during the Neonatal Period.

Neuropediatrics·2018
Same author

Impact of mutations within the [Fe-S] cluster or the lipoic acid biosynthesis pathways on mitochondrial protein expression profiles in fibroblasts from patients.

Molecular genetics and metabolism·2017
Same author

Chronic Diarrhea in L-Amino Acid Decarboxylase (AADC) Deficiency: A Prominent Clinical Finding Among a Series of Ten French Patients.

JIMD reports·2016
Same author

Genetic counselling difficulties and ethical implications of incidental findings from array-CGH: a 7-year national survey.

Clinical genetics·2015
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Urea cycle defects impact 217 patients, with neonatal and late-onset forms presenting distinct clinical outcomes. Long-term follow-up reveals significant mortality and disability risks, particularly in late-onset cases.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Urea cycle defects (UCDs) are inherited metabolic disorders affecting nitrogen excretion.
  • These disorders can manifest in neonatal or late-onset forms, posing significant health challenges.

Purpose of the Study:

  • To review the clinical presentation and long-term outcomes of a large cohort of patients with UCDs.
  • To analyze the differences in presentation and prognosis between neonatal-onset and late-onset UCDs.

Main Methods:

  • Retrospective review of clinical data from 217 patients diagnosed with UCDs.
  • Analysis of patient demographics, clinical symptoms, treatment, and long-term outcomes.
  • Specific focus on ornithine carbamoyltransferase deficiency in males with neonatal-onset disease.

Related Experiment Videos

Main Results:

  • The study included 121 patients with neonatal-onset UCDs and 96 with late-onset forms.
  • Neonatal forms, especially in ornithine carbamoyltransferase-deficient males, showed varying severity.
  • Late-onset UCDs presented at any age, with a 28% mortality rate and high risk of subsequent disabilities.

Conclusions:

  • Urea cycle defects represent a spectrum of disease with critical implications for patient survival and quality of life.
  • Early identification and management are crucial, especially for late-onset UCDs, given their substantial mortality and morbidity.
  • Further research into long-term management strategies for UCDs is warranted.